We know how important timely coverage for new drugs is. As one part of the drug reimbursement process, the pCPA is committed to supporting timely drug coverage for people in Canada.
That’s why we’re looking to improve and add to our negotiation pathway options by refreshing existing processes and introducing a new pathway for specific cancer drugs. These expedited negotiation pathways include the Early Negotiation Process (ENP), the Targeted Negotiation Process (TNP), and the pCPA Temporary Access Process (pTAP).
Thank you for your feedback
We recently sought input on both the ENP and the TNP. We’re grateful to everyone who provided their thoughts on TNP and our new Early Negotiations Process. The online survey is now closed and we’re reviewing feedback. We look forward to sharing a summary report of what we heard in December.